glp 1 medications australia Watchdog updates warnings for Ozempic-style drugs over potential risk of suicidal thoughts Broken PBS system behind failure

Packaged-food giant Conagra Foods is hoping to appeal to people taking weight-loss drugs with frozen entrees like chicken fettuccini alfredo or meatball

Learn about the latest science behind GLP-1 weight loss drugs, the nutritional needs of GLP-1 users and what this means for future innovation in food and beverage.

Learn about their unique characteristics, benefits, side effec...

A comprehensive literature search was conducted across the PubMed, Embase, and Google Scholar databases for peer-reviewed articles published from inception through June 15, 2026, focusing on the landmark SURPASS, SURMOUNT, and SUMMIT trial programs, relevant cardiorenal post hoc analyses, emerging body recomposition trials, and real-world cohort-switching protocols

A new GLP-1 study highlights why movement and strength support matter during medical weight loss with Ozempic, Wegovy, Mounjaro and Zepbound.

Background Limited data are available on the risk of pancreatic adverse events among people with obesity or type 2 diabetes mellitus (T2DM) initiating glucagon-like peptide-1 receptor agonist (GLP-1 RA)